Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.44 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.43 |
| ▸ | PPARG | P37231 | 7/20 | 0.43 |
| ▸ | PPARD | Q03181 | 7/20 | 0.43 |
| ▸ | PPARA | Q07869 | 7/20 | 0.43 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.43 |
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | TLR2 | O60603 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | FABP4 | P15090 | 2/20 | 0.43 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.43 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | PDE4A | P27815 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11839463 | 1.00 | CES2 (0.44) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL7782352 | 1.00 | CES2 (0.44) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL2702394 | 1.00 | CES2 (0.44) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL29175476 | 0.98 | CES2 (0.42) | CES2GPR84PPARGPPARDPPARA | |
| Ammonia Solution, Strong SCHEMBL29145548 | 0.98 | CES2 (0.42) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL22117083 | 0.96 | CES2 (0.41) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL27833356 | 0.96 | CES2 (0.39) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL28884013 | 0.92 | CES2 (0.41) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL2702976 | 0.91 | AKR1B1 (0.37) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL141054 | 0.89 | CES2 (0.38) | CES2GPR84PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10544086-B2 | Dialkyl carbonates of branched alcohols and their use | COGNIS IP MANAGEMENT GMBH (DE) | 2020-01-28 | — | — | US | disclosed |
| CN-104684865-B | Dust-proof cement composition | 圣戈班韦伯公司 | 2017-10-27 | — | — | CN | disclosed |
| US-20170260123-A1 | DIALKYL CARBONATES OF BRANCHED ALCOHOLS AND THEIR USE | COGNIS IP MANAGEMENT GMBH (DE) | 2017-09-14 | — | — | US | disclosed |
| CN-104684865-A | Anti-dust mortar composition | SAINT GOBAIN WEBER | 2015-06-03 | — | — | CN | disclosed |
| US-20100331565-A1 | Dialkyl Carbonates of Branched Alcohols and their Use | COGNIS IP MANAGEMENT GMBH (DE) | 2010-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10544086-B2 | Dialkyl carbonates of branched alcohols and their use | ADH1C, ADH1A, GALK1 | CES2 800/4885GPR84 2884/4885PPARG 267/4885 |
| US-20170260123-A1 | DIALKYL CARBONATES OF BRANCHED ALCOHOLS AND THEIR USE | ADH1C, ADH1A, GALK1 | CES2 800/4885GPR84 2884/4885PPARG 267/4885 |
| US-20100331565-A1 | Dialkyl Carbonates of Branched Alcohols and their Use | GALK1, BCKDK, ADH1C | CES2 573/4885GPR84 1634/4885PPARG 153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.